# Synlogic (SYBX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/SYBX
## Company Profile
- Ticker: SYBX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Microbial Products (Synthetic Biology), Cardio-Metabolic
## Stock Data
- Close: 1.1 USD
- Market cap: Not available USD
- Last updated: 2026-10-05
## Business Overview
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
## Why The Stock Is Moving

Current closing-price context is not available for SYBX.

## Geographic Base

Headquartered in the United States and listed on NASDAQ before restructuring, Synlogic sat in synthetic biology and biotechnology.

## Business Model

The company depended on platform validation, clinical proof, and the ability to turn engineered-microbe science into value.

## Landscape Position

Synlogic belongs to the historical synthetic-biology category rather than the current live public-company set.

## Future Catalysts

- Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is mainly waiting for clarity on what value, if any, remains.

## Recent News
- 2026-07-29 11:00 EST — [Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement](https://biopharmsignal.com/news/SYBX/synlogic-and-caldera-therapeutics-announce-merger-agreement-and-concurrent-priva-11695f09) — Source: Synlogic
- 2024-11-12 21:35 EST — [Synlogic Reports Third Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-third-quarter-2024-financial-results) — Source: Synlogic
- 2024-08-08 11:00 EST — [Synlogic Reports Second Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-second-quarter-2024-financial-results) — Source: Synlogic
- 2024-05-14 11:00 EST — [Synlogic Reports First Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-first-quarter-2024-financial-results) — Source: Synlogic
- 2024-03-19 11:00 EST — [Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-fourth-quarter-and-full-year-2023-financial-results) — Source: Synlogic